Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome

BACKGROUND Epigenetic alterations may provide valuable insights into gene-environment interactions play in the pathogenesis of Inflammatory Bowel Disease (IBD). METHODS Genome-wide methylation was measured from peripheral blood using the Illumina 450k platform in a case-control study in an inception cohort (295 controls, 154 CD, 161 UC, 28 IBD-U) with covariates of age, sex, and cell counts, deconvoluted by the Houseman method. Genotyping was performed using Illumina HumanOmniExpressExome-8 BeadChips and gene expression using Ion AmpliSeq Human Gene Expression Core Panel. Treatment escalation was characterised by the need for biological agents or surgery after initial disease remission. RESULTS A total of 137 differentially methylated positions (DMP) were identified in IBD, including VMP1/MIR21 (p=9.11×10 -15) and RPS6KA2 (6.43×10 -13); with consistency seen across Scandinavia and UK. Dysregulated loci demonstrate strong genetic influence, notably VMP1 (p=1.53×10 -15). Age acceleration is seen in IBD (coefficient 0.94, p<2.2x10 -16). Several immuno-active genes demonstrated highly significant correlations between methylation and gene expression in IBD, in particular OSM: IBD r -0.32, p 3.64×10 -7 vs. non-IBD r -0.14, p=0.77). Multi-omic integration of methylome, genome and transcriptome also implicate specific pathways that associate with immune activation, response and regulation at disease inception. At follow up, a signature of 3 DMPs (TAP1, TESPA1, RPTOR) associated with treatment escalation to biological agents or surgery (hazard ratio of 5.19 (CI:2.14-12.56, logrank p=9.70×10 -4). CONCLUSION These data demonstrate consistent epigenetic alterations at diagnosis in European patients with IBD, providing insights into the pathogenetic importance and translational potential of epigenetic mapping in complex disease.

[1]  G. Kaplan,et al.  The four epidemiological stages in the global evolution of inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[2]  D. Zerbino,et al.  Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis , 2020, Gastroenterology.

[3]  J. Marioni,et al.  MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data , 2020, Genome Biology.

[4]  J. Satsangi,et al.  Blood-based DNA methylation in Crohn's disease and severity of intestinal inflammation. , 2019, Translational gastroenterology and hepatology.

[5]  Heini M. Natri,et al.  Genome-wide DNA methylation and gene expression patterns reflect genetic ancestry and environmental differences across the Indonesian archipelago , 2019, bioRxiv.

[6]  Andrew E. Teschendorff,et al.  eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data , 2019, Bioinform..

[7]  Judy H. Cho,et al.  Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation. , 2019, Gastroenterology.

[8]  Kenneth G. C. Smith,et al.  A blood-based prognostic biomarker in IBD , 2019, Gut.

[9]  S. Vermeire,et al.  Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease , 2019, EBioMedicine.

[10]  H. Ling,et al.  Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses , 2018, Mucosal Immunology.

[11]  George Davey Smith,et al.  Meffil: efficient normalization and analysis of very large DNA methylation datasets , 2018, Bioinform..

[12]  S. Shen-Orr,et al.  Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD , 2018, Gut.

[13]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[14]  Ting Qi,et al.  Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits , 2018, Nature Communications.

[15]  N. Roetker,et al.  Prospective Study of Epigenetic Age Acceleration and Incidence of Cardiovascular Disease Outcomes in the ARIC Study (Atherosclerosis Risk in Communities) , 2018, Circulation. Genomic and precision medicine.

[16]  E. Ingelsson,et al.  Methylation‐based estimated biological age and cardiovascular disease , 2018, European journal of clinical investigation.

[17]  P. Rosenstiel,et al.  DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome , 2017, Gastroenterology.

[18]  A. Nassar,et al.  Downregulation of TAP1 and TAP2 in early stage breast cancer , 2017, PloS one.

[19]  R. Palmqvist,et al.  TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer , 2017, Oncoimmunology.

[20]  G. Müller-Newen,et al.  Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease , 2017, Zeitschrift für Gastroenterologie.

[21]  Judy H. Cho,et al.  Transcriptional Risk Scores link GWAS to eQTL and Predict Complications in Crohn's Disease , 2017, Nature Genetics.

[22]  Judy H. Cho,et al.  Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study , 2017, The Lancet.

[23]  Min A. Jhun,et al.  DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases , 2016, Genome Biology.

[24]  H. Drummond,et al.  Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases , 2016, The American Journal of Gastroenterology.

[25]  M. Levine,et al.  DNA methylation-based measures of biological age: meta-analysis predicting time to death , 2016, Aging.

[26]  Noah Zaitlen,et al.  Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures , 2016, bioRxiv.

[27]  V. Rakyan,et al.  Assessing DNA methylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease , 2015, Mucosal Immunology.

[28]  Fredrik Dahl,et al.  Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease , 2016, Nature Communications.

[29]  H. Brenner,et al.  DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies , 2015, Clinical Epigenetics.

[30]  S. Horvath,et al.  DNA methylation age of blood predicts all-cause mortality in later life , 2015, Genome Biology.

[31]  Nilesh J Samani,et al.  Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation , 2014, Epigenetics.

[32]  H. Drummond,et al.  Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohn's Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci , 2014, Inflammatory bowel diseases.

[33]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[34]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[35]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[36]  H. Shiraha,et al.  Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis , 2013, PloS one.

[37]  T. Marquès-Bonet,et al.  DNA methylation contributes to natural human variation , 2013, Genome research.

[38]  Richard Hansen,et al.  Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis , 2012, The American Journal of Gastroenterology.

[39]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[40]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[41]  Andrey A. Shabalin,et al.  Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..

[42]  Peter A. Jones,et al.  DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. , 2011, Human molecular genetics.

[43]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[44]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[45]  M. Dowsett,et al.  ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. , 2008, Endocrine-related cancer.

[46]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[47]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[48]  H. Drummond,et al.  Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. , 2004, Gastroenterology.

[49]  J. Lennard-jones,et al.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). , 1996, Gut.

[50]  L. Sklar,et al.  P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. , 1996, Blood.

[51]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[52]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .